Venture capital firm W Health Ventures has announced the initial close of its second fund at ₹550 crore, with a target corpus of ₹630 crore, to incubate and scale healthcare companies across India and the US-India corridor.
Fund II will focus on building 8–10 new healthcare ventures over the next four years, deploying investments of ₹30–50 crore per company. The firm follows a company-building model, co-founding startups from inception and developing technology-led solutions in underserved clinical and operational segments.
The new fund will target high-impact areas such as oncology, preventive health, geriatrics, and chronic care management, reflecting growing demand for scalable and digitally enabled healthcare models.
Everhope Oncology, a national oncology platform established in partnership with Narayana Health, is the first company launched under Fund II. The firm is also incubating a US-based psychiatry platform aimed at expanding access to advanced treatments for patients with treatment-resistant depression.
According to the firm, companies backed under its first fund have collectively reached 25 million lives globally, and Fund II is positioned to significantly expand that footprint over the coming years.
With fresh capital commitments from limited partners, W Health Ventures plans to deepen its cross-border healthcare innovation strategy, building scalable platforms designed to address structural gaps in care delivery while leveraging digital infrastructure and clinical expertise.
